Company intelligence / Profile preview

Laurentis Energy Partners

Toronto, Ontario, Canada

Ownership: Private
Employees: ~384
Development stage: Other

Overview

Laurentis Energy Partners, a subsidiary of Ontario Power Generation, is commercially producing medical isotopes including lutetium-177 and yttrium-90 for cancer therapy, with regulatory clearance to expand production and a proprietary Target Delivery System; they are one of a few suppliers meeting global shortages, and their uptake is expanding rapidly in radiopharmaceuticals.

Therapeutic areas: OncologyInfectious Diseases
Modalities: RadiopharmaceuticalRadiopharmaceutical (yttrium-90)Radiopharmaceutical (lutetium-177)Radiopharmaceutical (molybdenum-99)Radiopharmaceutical (cobalt-60)Radiopharmaceutical (helium-3)
Industry: Chemicals & Materials

Partnerships

BWXT Medical Ltd.Colibri Isotopes Corporation

Beyond the preview

Go deeper on Laurentis Energy Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Laurentis Energy Partners.

Explore the full profile